METROPOLITAN LIFE INSURANCE CO/NY - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 78 filers reported holding UROGEN PHARMA LTD in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q3 2023$15,103
+35.4%
1,0780.0%0.00%0.0%
Q2 2023$11,157
-88.1%
1,078
-80.6%
0.00%0.0%
Q3 2021$93,570
-21.1%
5,563
-8.7%
0.00%
-50.0%
Q1 2021$118,653
+8.1%
6,0910.0%0.00%0.0%
Q4 2020$109,760
-31.0%
6,0910.0%0.00%
-33.3%
Q2 2020$159,097
-7.6%
6,091
-15.7%
0.00%0.0%
Q3 2019$172,2197,2270.00%
Other shareholders
UROGEN PHARMA LTD shareholders Q4 2021
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,111,050$9,099,0004.23%
GREAT POINT PARTNERS LLC 873,424$7,153,0001.72%
Wildcat Capital Management, LLC 533,139$4,366,0001.45%
Opaleye Management Inc. 238,670$1,955,0000.88%
MENORA MIVTACHIM HOLDINGS LTD. 2,949,489$24,156,0000.44%
Annandale Capital, LLC 84,331$691,0000.27%
Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. 25,330$206,0000.18%
RTW INVESTMENTS, LP 857,464$7,023,0000.18%
Harel Insurance Investments & Financial Services Ltd. 1,025,611$8,400,0000.18%
BENDER ROBERT & ASSOCIATES 41,131$337,0000.13%
View complete list of UROGEN PHARMA LTD shareholders